Literature DB >> 18061252

Hepatocellular carcinoma: epidemiology and clinical aspects.

Roberto Mazzanti1, Laura Gramantieri, Luigi Bolondi.   

Abstract

Liver cancer is one of the most frequent solid cancers that kills more than 650,000 people around the world each year. Though great improvements have been done in last 10 years on the understanding the molecular mechanisms involved in liver oncogenesis, the prognosis of patients affected by liver cancer is still poor for most of them. Even in those where a relatively early diagnosis is done, the course of the disease is often fatal due to the underlying liver cirrhosis. In this review authors report the most recent findings on the pathogenesis of liver cancer and on therapeutic approaches, included those emerging from the most recent literature.

Entities:  

Mesh:

Year:  2007        PMID: 18061252     DOI: 10.1016/j.mam.2007.09.008

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  36 in total

Review 1.  Positron emission tomography diagnostic imaging in multidrug-resistant hepatocellular carcinoma: focus on 2-deoxy-2-(18F)Fluoro-D-Glucose.

Authors:  Ana F Brito; Mónica Mendes; Ana M Abrantes; José G Tralhão; Maria F Botelho
Journal:  Mol Diagn Ther       Date:  2014-10       Impact factor: 4.074

Review 2.  Hepatocellular carcinoma: Where are we?

Authors:  Roberto Mazzanti; Umberto Arena; Renato Tassi
Journal:  World J Exp Med       Date:  2016-02-20

3.  Malic enzyme 1 induces epithelial-mesenchymal transition and indicates poor prognosis in hepatocellular carcinoma.

Authors:  Duo Wen; Dongli Liu; Jun Tang; Lili Dong; Yang Liu; Zhonghua Tao; Jinliang Wan; Dongmei Gao; Lu Wang; Huichuan Sun; Jia Fan; Weizhong Wu
Journal:  Tumour Biol       Date:  2015-03-10

4.  Hepatic resection combined with radiofrequency ablation versus hepatic resection alone for multifocal hepatocellular carcinomas: A meta-analysis.

Authors:  Liang-Liang Xu; Ming Zhang; Peng-Sheng Yi; Xiao-Bo Zheng; Lei Feng; Chuan Lan; Jian-Wei Tang; Sheng-Sheng Ren; Ming-Qing Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-12-21

5.  Antitumor effect of matrine in human hepatoma G2 cells by inducing apoptosis and autophagy.

Authors:  Jun-Qiang Zhang; Yu-Min Li; Tao Liu; Wen-Ting He; Ying-Tai Chen; Xiao-Hui Chen; Xun Li; Wen-Ce Zhou; Jian-Feng Yi; Zhi-Jian Ren
Journal:  World J Gastroenterol       Date:  2010-09-14       Impact factor: 5.742

6.  Clinical significance of miR-221 and its inverse correlation with p27Kip¹ in hepatocellular carcinoma.

Authors:  Xinhui Fu; Qian Wang; Jingsong Chen; Xiaohui Huang; Xilin Chen; Liangqi Cao; Haoxiang Tan; Wen Li; Longjuan Zhang; Jiong Bi; Qiao Su; Lianzhou Chen
Journal:  Mol Biol Rep       Date:  2010-02-10       Impact factor: 2.316

7.  Glypican-3, a novel prognostic marker of hepatocellular cancer, is related with postoperative metastasis and recurrence in hepatocellular cancer patients.

Authors:  Su Ning; Chen Bin; Huang Na; Shen Peng; Ding Yi; Ye Xiang-hua; Zeng Fang-yin; Zheng Da-yong; Luo Rong-cheng
Journal:  Mol Biol Rep       Date:  2011-06-08       Impact factor: 2.316

8.  Quantitative proteomics and phosphoproteomics on serial tumor biopsies from a sorafenib-treated HCC patient.

Authors:  Eva Dazert; Marco Colombi; Tujana Boldanova; Suzette Moes; David Adametz; Luca Quagliata; Volker Roth; Luigi Terracciano; Markus H Heim; Paul Jenoe; Michael N Hall
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-19       Impact factor: 11.205

9.  Tumor-infiltrating plasmacytoid dendritic cells promote immunosuppression by Tr1 cells in human liver tumors.

Authors:  Alexander Pedroza-Gonzalez; Guoying Zhou; Ernesto Vargas-Mendez; Patrick Pc Boor; Shanta Mancham; Cornelis Verhoef; Wojciech G Polak; Dirk Grünhagen; Qiuwei Pan; Harry LA Janssen; Gina S Garcia-Romo; Katharina Biermann; Eric Ttl Tjwa; Jan Nm IJzermans; Jaap Kwekkeboom; Dave Sprengers
Journal:  Oncoimmunology       Date:  2015-03-19       Impact factor: 8.110

10.  Differential proteomics identification of HSP90 as potential serum biomarker in hepatocellular carcinoma by two-dimensional electrophoresis and mass spectrometry.

Authors:  Yiyi Sun; Zhihe Zang; Xiaohong Xu; Zhonglin Zhang; Ling Zhong; Wang Zan; Yan Zhao; Lin Sun
Journal:  Int J Mol Sci       Date:  2010-03-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.